9/12, 3:34 PM (Source: TeleTrader)
more TeleTrader news

AstraZeneca vaccine trial resumed in UK

Clinical trials for the COVID-19 vaccine developed by AstraZeneca plc and University resumed in the United Kingdom following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to proceed, the company announced on Saturday.

The trials were paused on September 8 after one of the participants experienced severe neurological symptoms.

"The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume," AstraZeneca said.

Breaking the News / MD